ReviewDrug design, development and therapy2017

Sofosbuvir/velpatasvir regimen promises an effective pan-genotypic hepatitis C virus cure.

Fazia Mir et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.